Biogen Idec received a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for the marketing authorisation of Plegridy™ (peginterferon beta-1a), a pegylated interferon administered subcutaneously for adults with relapsing-remitting multiple sclerosis (RRMS).
The CHMP’s positive opinion is now referred to the European Commission (EC), which grants marketing authorization for medicines in the EU........ Read More - http://www.ms-uk.org/PEGylatedinterferonbeta
CHMP adopts positive opinion for MS drug Plegridy™ in EU
CHMP adopts positive opinion for MS drug Plegridy™ in EU
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 2 Replies
- 2231 Views
-
Last post by NHE
-
- 8 Replies
- 7542 Views
-
Last post by Algis
-
- 0 Replies
- 522 Views
-
Last post by NHE
-
- 0 Replies
- 1670 Views
-
Last post by NHE
-
- 1 Replies
- 3164 Views
-
Last post by Tif
-
- 0 Replies
- 126 Views
-
Last post by DIM
-
- 2 Replies
- 1085 Views
-
Last post by DIM
-
- 1 Replies
- 1994 Views
-
Last post by raceya